Melatonin and N-acetylcysteine influence on the lipoperoxidation intensity in blood serum and central nervous system of rats with type 1 diabetes mellitus
DOI:
https://doi.org/10.24959/ubphj.18.182Keywords:
experimental diabetes mellitus, fatty acids, brain, antioxidants, N-acetylcysteine, melatoninAbstract
Topicality. Diabetic encephalopathy has a significant medical and social value, since it is one of the most common complications of diabetes mellitus. Medicines with antioxidative properties play an important role in pathogenetic therapy of diabetic encephalopathy.
Aim. To investigate the effect of melatonin and N-acetylcysteine on the lipoperoxidation intensity in blood serum and central nervous system of rats with streptozotocin – induced diabetes mellitus type 1 (DM1).
Materials and methods. MDA and SOD were studied in homogenate of brain tissues and blood serum of rats (with DM1 received physiological solution; rats with DM1 received per os: N-acetylcysteine at a dose of 1.5 g/kg – (NAC), melatonin – 10 mg/kg (Mel) and combination therapy (NAC + Mel); healthy rats (control group)). Fatty acid composition was determined by gas-liquid chromatography.
Results and discussion. We observed the growth of MDA, reduction of SOD in homogenate of brain tissues and growth of MDA in blood serum of rats with DM comparison groups. Administration of NAC and Mel was contributed to the reduction of MDA concentration and normalization of SOD level in homogenate of brain tissues. Administration of Mel was contributed to the reduction of MDA concentration and growing of SOD in serum blood also. Pharmacotherapy NAC and Mel was caused normalization of the fatty acids in the brain of rats with diabetes type 1: the levels of palmitic and linoleum acids were increased, and the level of arachidonic acid was decreased. Mel increased the level of oleic acid also. NAC in mono- and combination therapy contributed to the improvement of the fatty acid composition in blood serum`s lipids of rats with diabetes mellitus type 1 by reducing the amount of saturated and increasing unsaturated and polyunsaturated fatty acids. Mel also increased the content of unsaturated fatty acids in blood serum.
Conclusions. Therapy of NAC and Mel caused to the decreasing in the intensity of lipoperoxidation in the blood serum and central nervous system of rats with streptozotocin – induced type 1 diabetes mellitus.
References
Tkachenko, V. I. (2014). Liky Ukrainy, 4, 55–59.
Pankiv V. I. (2012). Pathogenetic treatment of Diabetic Neuropathy: an integrated approach To the practicing endocrinologist. mif-ua.com. Available
at: www.mif-ua.com/archive/article/34898.
Sözbir, E., & Nazıroğlu, M. (2015). Diabetes enhances oxidative stress-induced TRPM2 channel activity and its control by N-acetylcysteine in rat
dorsal root ganglion and brain. Metabolic Brain Disease, 31 (2), 385–393. https://doi.org/10.1007/s11011-015-9769-7
Özcelik, D., Uzun, H., & Nazıroglu, M. (2012). N-Acetylcysteine Attenuates Copper Overload-Induced Oxidative Injury in Brain of Rat. Biological
Trace Element Research, 147 (1-3), 292–298. https://doi.org/10.1007/s12011-012-9320-1
Şenol, N., Nazıroğlu, M., & Yürüker, V. (2014). N-Acetylcysteine and Selenium Modulate Oxidative Stress, Antioxidant Vitamin and Cytokine Values
in Traumatic Brain Injury-Induced Rats. Neurochemical Research, 39 (4), 685–692. https://doi.org/10.1007/s11064-014-1255-9
Rosa, L. R. de O., Kaga, A. K., Barbanera, P. O., Queiroz, P. M., do Carmo, N. O. L., & Fernandes, A. A. H. (2018). Beneficial effects of N-acetylcysteine
on hepatic oxidative stress in streptozotocin-induced diabetic rats. Canadian Journal of Physiology and Pharmacology, 96 (4), 412–418. https://
doi.org/10.1139/cjpp-2017-0559
Heo, J.-I., Yoon, D. W., Yu, J. H., Kim, N. H., Yoo, H. J., Seo, J. A., … Kim, N. H. (2018). Melatonin improves insulin resistance and hepatic steatosis
through attenuation of alpha-2-HS-glycoprotein. Journal of Pineal Research, e12493. https://doi.org/10.1111/jpi.12493
Konenkov, V. I., Klimontov, V. V., Michurina, S. V. Prudnikova, M. A., Ishchenko, I. Iu. (2013). Saharnyj diabet, 2, 11–16.
Kadry, S. M., El-Dakdoky, M. H., Haggag, N. Z., Rashed, L. A., & Hassen, M. T. (2018). Melatonin improves the therapeutic role of mesenchymal stem
cells in diabetic rats. Toxicology Mechanisms and Methods, 28 (7), 529–538. https://doi.org/10.1080/15376516.2018.1471634
Zhou, H., Yue, Y., Wang, J., Ma, Q., & Chen, Y. (2018). Melatonin therapy for diabetic cardiomyopathy: A mechanism involving Syk-mitochondrial
complex I-SERCA pathway. Cellular Signalling, 47, 88–100. https://doi.org/10.1016/j.cellsig.2018.03.012
Bicer, M., Baltaci, S. B., Patlar, S., Mogulkoc, R., & Baltaci, A. K. (2018). Melatonin has a protective effect against lipid peroxidation in the bone tissue
of diabetic rats subjected to acute swimming exercise. Hormone Molecular Biology and Clinical Investigation, 0 (0). https://doi.org/10.1515/
hmbci-2017-0079
Mehrzadi, S., Motevalian, M., Rezaei Kanavi, M., Fatemi, I., Ghaznavi, H., & Shahriari, M. (2018). Protective effect of melatonin in the diabetic rat
retina. Fundamental & Clinical Pharmacology, 32 (4), 414–421. https://doi.org/10.1111/fcp.12361
Seyit, D., Degirmenci, E., & Oguzhanoglu, A. (2016). Evaluation of Electrophysiological Effects of Melatonin and Alpha Lipoic Acid in Rats with Streptozotocine Induced Diabetic Neuropathy. Experimental and Clinical Endocrinology & Diabetes, 124 (05), 300–306. https://doi.org/10.1055/s-0042-103750
Rafieian-Kopaei, M., Sharafati-Chaleshtori, R., Shirzad, H., & Soltani, A. (2017). Melatonin and human mitochondrial diseases. Journal of Research
in Medical Sciences, 22 (1), 2. https://doi.org/10.4103/1735-1995.199092
Council Directive 2010/63/EU of 22 September 2010 on the protection of animals used for scientific purposes. (2010). Official Journal of the
European Communities, 276, 33–79.
Stefanov, O. V. (2001). Doklinichni doslidzhennya likarskih zasobiv. Kyiv: «Avitsena», 528.
Stalnaia, I. D., Havryshvili, T.H. (1977). Metod opredeleniia MDA s pomoshchiu tiobarbiturovoi kisloty. Orekhovycha, V. N. (ed). Sovremennye metody v biokhimii. M.: Meditcina, 66–67.
Sirota, T. V. (1999). Voprosy meditcinskoi khimii, 45 (3), 263–271.
Yaremenko, O. B., Briuzghina, T. S., Kamysh, T. S., Vretyk, H. M. (2005). Medychna khimiia, 7 (2), 86–88.
Lamazian, H. R., Sytnyk, I. M., Natrus, L. V., Bruzgina, T. S., Chernovol, P. A., & Rizhko, I. M. (2016). Investigation of antioxidant defense mechanisms
of Citrullus Colocynthis fruits and N-acetylcysteine in the diabetes mellitus model on rats. Zaporozhye Medical Journal, 0 (5). https://
doi.org/10.14739/2310-1210.2016.5.82685
Nahorna, O. O., Horchakova, N. O., Chekman, I. S., Bielenichev, I., Briuzghina, T. (2014). Farmakolohiia ta likarska toksykolohiia, 1, 73–77.
Katiuzhinskaia, S. G. (2014). Aktualnye problemy transportnoi meditciny, 155–160.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
